Frontiers | Contribution of system biology technologies to disease-modifying drug development for neurodegeneration.

Contribution of system biology technologies to disease-modifying drug development for neurodegeneration.

2,534
Total downloads
11k
Total views and downloads

Articles

PERSPECTIVE

Published on 09 May 2017

Positive Modulatory Interactions of NMDA Receptor GluN1/2B Ligand Binding Domains Attenuate Antagonists Activity

Douglas Bledsoe
Ceyhun Tamer
Ivana Mesic
Christian Madry
Bradley G. Klein
Bodo Laube
Blaise M. Costa

Positive Modulatory Interactions of NMDA Receptor GluN1/2B Ligand Binding Domains Attenuate Antagonists Activity

doi 10.3389/fphar.2017.00229

3,586 views
6 citations

ORIGINAL RESEARCH

Published on 26 Jan 2017

Classification of Healthy Subjects and Alzheimer's Disease Patients with Dementia from Cortical Sources of Resting State EEG Rhythms: A Study Using Artificial Neural Networks

Antonio I. Triggiani
Vitoantonio Bevilacqua
Antonio Brunetti
Roberta Lizio
Giacomo Tattoli
Fabio Cassano
Andrea Soricelli
Raffaele Ferri
Flavio Nobili
17 more
Claudio Babiloni

Classification of Healthy Subjects and Alzheimer's Disease Patients with Dementia from Cortical Sources of Resting State EEG Rhythms: A Study Using Artificial Neural Networks

doi 10.3389/fnins.2016.00604

6,087 views
56 citations

Share on

Frontiers in Neuroscience

Frontiers in Neuroscience

Neuropharmacology

Participating Journals

Frontiers in Pharmacology
- Neuropharmacology
- 4.4 impact factor
- 7.8 citescore

Impact

11kTopic views
7,588Article views
2,534Article downloads